Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 4
1980 2
1982 1
1983 2
1984 1
1989 1
1990 1
1991 1
1992 2
1993 1
1994 3
1995 4
1996 2
1997 4
1998 6
1999 6
2000 8
2001 8
2002 20
2003 37
2004 43
2005 42
2006 28
2007 29
2008 33
2009 57
2010 59
2011 55
2012 72
2013 104
2014 116
2015 120
2016 113
2017 106
2018 139
2019 148
2020 130
2021 118
2022 98
2023 91
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

1,602 results

Results by year

Filters applied: . Clear all
Page 1
Risk Factors for the Development of Psoriasis.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Kamiya K, et al. Int J Mol Sci. 2019 Sep 5;20(18):4347. doi: 10.3390/ijms20184347. Int J Mol Sci. 2019. PMID: 31491865 Free PMC article. Review.
In addition, psoriasis may be associated with other auto-inflammatory and auto-immune diseases. In this review, we summarize the risk factors, which can be divided into two groups (namely, extrinsic and intrinsic risk factors), responsible for the onset and e …
In addition, psoriasis may be associated with other auto-inflammatory and auto-immune diseases. In this review, we summarize the r
Risk of infections in psoriasis: assessment and challenges in daily management.
De Simone C, Fargnoli MC, Amerio P, Bianchi L, Esposito M, Pirro F, Potenza C, Ricceri F, Rongioletti F, Stingeni L, Prignano F. De Simone C, et al. Expert Rev Clin Immunol. 2021 Nov;17(11):1211-1220. doi: 10.1080/1744666X.2021.1997592. Epub 2021 Nov 1. Expert Rev Clin Immunol. 2021. PMID: 34696673 Review.
INTRODUCTION: In daily practice management of psoriasis, evaluation of risk factors for infections is having a growing influence. Indeed, in psoriatic patients, risk of infections may be due to psoriasis itself, immunomodulatory therapy, and comorbidit …
INTRODUCTION: In daily practice management of psoriasis, evaluation of risk factors for infections is having a growing influen …
[Recommendations for individual comorbidity risk assessment in adult patients with psoriasis].
Wohlrab J, Körber A, Adler G, Blüher M, Zirlik A, Gerdes S. Wohlrab J, et al. Dermatologie (Heidelb). 2023 May;74(5):350-355. doi: 10.1007/s00105-023-05116-7. Epub 2023 Feb 22. Dermatologie (Heidelb). 2023. PMID: 36811642 Free PMC article. Review. German.
It has long been known that chronic inflammatory systemic diseases, such as psoriasis, pose a high risk of developing comorbidities. In everyday clinical practice, it is therefore of particular importance to identify patients who have an individually increased ri
It has long been known that chronic inflammatory systemic diseases, such as psoriasis, pose a high risk of developing comorbid …
Psoriasis and psoriatic arthritis overview.
Menter A. Menter A. Am J Manag Care. 2016 Jun;22(8 Suppl):s216-24. Am J Manag Care. 2016. PMID: 27356193 Free article. Review.
Effective management requires timely diagnosis and initiation of treatment. Yet, both psoriasis and PsA remain underrecognized and undertreated in current clinical practice. Recognizing the true physical, social, and emotional burden of psoriasis and PsA, as well as …
Effective management requires timely diagnosis and initiation of treatment. Yet, both psoriasis and PsA remain underrecognized and un …
Psoriasis and cardiovascular risk. Assessment by different cardiovascular risk scores.
Fernández-Torres R, Pita-Fernández S, Fonseca E. Fernández-Torres R, et al. J Eur Acad Dermatol Venereol. 2013 Dec;27(12):1566-70. doi: 10.1111/j.1468-3083.2012.04618.x. Epub 2012 Jun 25. J Eur Acad Dermatol Venereol. 2013. PMID: 22731956
OBJECTIVES: To determine multiple cardiovascular risk scores in psoriasis patients, the relation between cardiovascular risk and psoriasis features and to compare our results with those in the literature. ...Cardiovascular risk was not related t …
OBJECTIVES: To determine multiple cardiovascular risk scores in psoriasis patients, the relation between cardiovascular ris
Risk-benefit assessment of methotrexate in the treatment of severe psoriasis.
Kuijpers AL, van de Kerkhof PC. Kuijpers AL, et al. Am J Clin Dermatol. 2000 Jan-Feb;1(1):27-39. doi: 10.2165/00128071-200001010-00003. Am J Clin Dermatol. 2000. PMID: 11702302 Review.
Methotrexate is an established and highly effective systemic treatment for severe psoriasis, including the pustular and erythrodermic forms. It has been widely used during the last 3 decades. ...Because hepatotoxicity is related to a high cumulative dose of methotrexate, r …
Methotrexate is an established and highly effective systemic treatment for severe psoriasis, including the pustular and erythrodermic …
Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature.
Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Maitre ML, Richard-Lallemand MA, Ortonne JP. Prey S, et al. J Eur Acad Dermatol Venereol. 2010 Apr;24 Suppl 2:31-5. doi: 10.1111/j.1468-3083.2009.03565.x. J Eur Acad Dermatol Venereol. 2010. PMID: 20443998 Review.
OBJECTIVE: The aim of this study was to determine the prevalence of psoriatic arthritis (PsA) in the patients with plaque psoriasis and to give recommendation for the diagnosis of PsA for dermatologists. ...With the eight studies using rheumatologically validated criteria, …
OBJECTIVE: The aim of this study was to determine the prevalence of psoriatic arthritis (PsA) in the patients with plaque psoriasis a …
Performance of Coronary Artery Calcium Testing in Patients With Severe Psoriasis: Risk Assessment and Reclassification Potential in a Low Cardiovascular Risk Population.
Martinez-Domenech A, Forner Giner J, Pérez-Pastor G, Magdaleno-Tapial J, Herraez-Cervera B, Sánchez-Carazo JL, Martínez-Leon J, Pérez-Ferriols A. Martinez-Domenech A, et al. Actas Dermosifiliogr. 2022 Sep;113(8):773-780. doi: 10.1016/j.ad.2022.04.013. Epub 2022 May 4. Actas Dermosifiliogr. 2022. PMID: 35523308 Free article. English, Spanish.
Coronary artery calcium (CAC) testing can detect subclinical CAD and improve cardiovascular risk assessment beyond clinical scores. OBJECTIVES: Evaluate the presence and magnitude of subclinical CAD determined by CAC score among the different ESC/EAS CV risk
Coronary artery calcium (CAC) testing can detect subclinical CAD and improve cardiovascular risk assessment beyond clinical sc …
Cardiovascular risk and psoriasis: a role in clinical cardiology?
Imbalzano E, Casale M, D'Angelo M, Mandraffino G, Giugno V, Di Bella G, Carerj S, Dattilo G. Imbalzano E, et al. Angiology. 2015 Feb;66(2):101-3. doi: 10.1177/0003319714527339. Epub 2014 Mar 25. Angiology. 2015. PMID: 24671131 Review. No abstract available.
Cardiovascular risk and psoriasis: beyond the traditional risk factors.
Coumbe AG, Pritzker MR, Duprez DA. Coumbe AG, et al. Am J Med. 2014 Jan;127(1):12-8. doi: 10.1016/j.amjmed.2013.08.013. Epub 2013 Oct 23. Am J Med. 2014. PMID: 24161194 Review.
Similar to atherosclerosis, inflammation is integral to the initiation and propagation of plaque development. Mounting evidence has emerged demonstrating that psoriasis not only is associated with increased prevalence of cardiovascular risk factors, but also is an i …
Similar to atherosclerosis, inflammation is integral to the initiation and propagation of plaque development. Mounting evidence has emerged …
1,602 results